Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 294,512	$ 107,870
Short-term investments	81,574	74,510
Accounts receivable, net	267,125	434,266
Prepaid expenses	13,317	17,108
Income taxes receivable	22,797	0
Other current assets	20,287	11,837
Assets held for sale	951,548	85,916
Total current assets	1,651,160	731,507
Property and equipment, net	78,570	72,677
Goodwill	1,480,668	1,479,850
Intangible assets, net	27,665	28,587
Operating lease right-of-use assets	58,993	56,413
Deferred income tax assets	62,950	86,644
Other assets	64,820	48,643
Assets held for sale	0	1,641,580
Total assets	3,424,826	4,145,901
Current liabilities:
Accounts payable and accrued expenses	388,517	410,637
Current portion of finance lease liabilities	2,440	0
Current portion of operating lease liabilities	18,695	18,254
Income taxes payable	0	6,039
Liabilities held for sale	78,712	106,888
Total current liabilities	488,364	541,818
Long-term debt and finance lease liabilities, net	1,742,263	1,730,238
Long-term operating lease liabilities	40,220	44,643
Long-term professional liabilities	242,366	204,914
Deferred income tax liabilities	63,630	56,468
Other liabilities	42,977	22,819
Liabilities held for sale	0	46,005
Total liabilities	2,619,820	2,646,905
Shareholders' equity:
Preferred stock; $.01 par value; 1,000 shares authorized; none issued	0	0
Common stock; $.01 par value; 200,000 shares authorized; 85,504 and 84,248 shares issued and outstanding, respectively	855	842
Additional paid-in capital	1,023,974	987,942
Accumulated other comprehensive income	1,990	78
Retained (deficit) earnings	(222,058)	510,134
Total MEDNAX, Inc. shareholders' equity	804,761	1,498,996
Noncontrolling interest	245	0
Total equity	805,006	1,498,996
Total liabilities and equity	$ 3,424,826	$ 4,145,901